Author

Ling Yi

National Institutes of HealthORCID 0000-0001-5250-214XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ling Yi1 paper · Second Military Medical University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:variant calling· 1 Organism:zebrafish· 1

Frequent Co-Authors

Benjamin FeldmaniD· 1 shared Chon‐Hwa Tsai‐MorrisiD· 1 shared Eric Chang· 1 shared James IbeniD· 1 shared Ryan DaleiD· 1 shared Stephen Gerard KaleriD· 1 shared Steven L. CooniD· 1 shared Sydney Hertafeld· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Benjamin FeldmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GeneticsbioRxivPreprintApr 20, 2021

Detection of precisely edited CRISPR/Cas9 alleles through cointroduced restriction-fragment length polymorphisms

Chon‐Hwa Tsai‐Morris, Sydney Hertafeld, Yvonne V Rosario…·Benjamin Feldman

The paper introduces TIARS, a method to detect precise CRISPR/Cas9 edits using restriction-fragment length polymorphisms, and validates it in zebrafish for atp7a gene mutations.

DOI 10.1101/2021.04.20.440537

zebrafishCRISPR screen

𝕏 PostBluesky